Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Herpes zoster-attributable resource utilization and cost burden in patients with solid organ transplant.

Palmer L, White RR, Johnson BH, Fowler R, Acosta CJ.

Transplantation. 2014 Jun 15;97(11):1178-84. doi: 10.1097/01.tp.0000461121.98312.75.

PMID:
24892964
2.

Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.

White RR, Lenhart G, Singhal PK, Insinga RP, Itzler RF, Pellissier JM, Segraves AW.

Pharmacoeconomics. 2009;27(9):781-92. doi: 10.2165/11317560-000000000-00000.

PMID:
19757871
3.

Health care expenditure burden of persisting herpes zoster pain.

Dworkin RH, White R, O'Connor AB, Hawkins K.

Pain Med. 2008 Apr;9(3):348-53. doi: 10.1111/j.1526-4637.2006.00196.x.

4.

Economic burden of herpes zoster among skilled nursing facility residents in the United States.

Ma L, White RR, Narayanan S, Schmader KE.

J Am Med Dir Assoc. 2012 Jan;13(1):54-9. doi: 10.1016/j.jamda.2010.03.015. Epub 2010 Oct 2.

PMID:
21450176
5.

The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid.

Jacobson JJ, Epstein JB, Eichmiller FC, Gibson TB, Carls GS, Vogtmann E, Wang S, Murphy B.

Head Neck Oncol. 2012;4:15. doi: 10.1186/1758-3284-4-15. Epub 2012 Apr 26.

6.

Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.

Insinga RP, Itzler RF, Pellissier JM.

Pharmacoeconomics. 2007;25(2):155-69.

PMID:
17249857
7.

Health care utilization and cost burden of herpes zoster in a community population.

Yawn BP, Itzler RF, Wollan PC, Pellissier JM, Sy LS, Saddier P.

Mayo Clin Proc. 2009 Sep;84(9):787-94. doi: 10.1016/S0025-6196(11)60488-6. Erratum in: Mayo Clin Proc. 2010 Jan;85(1):102.

8.

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009.

Dalal AA, Liu F, Riedel AA.

Int J Chron Obstruct Pulmon Dis. 2011;6:533-42. doi: 10.2147/COPD.S24591. Epub 2011 Oct 14.

9.

Incidence of herpes zoster in patients with altered immune function.

Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ.

Infection. 2014 Apr;42(2):325-34. doi: 10.1007/s15010-013-0550-8. Epub 2013 Nov 10.

10.

Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster.

Dworkin RH, White R, O'Connor AB, Baser O, Hawkins K.

J Am Geriatr Soc. 2007 Aug;55(8):1168-75.

PMID:
17661954
11.

Burden of diabetic foot ulcers for medicare and private insurers.

Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB.

Diabetes Care. 2014;37(3):651-8. doi: 10.2337/dc13-2176. Epub 2013 Nov 1. Erratum in: Diabetes Care. 2014 Sep;37(9):2660.

PMID:
24186882
12.

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.

Pelletier EM, Ogale S, Yu E, Brunetta P, Garg J.

Clin Ther. 2009 Nov;31(11):2653-64. doi: 10.1016/j.clinthera.2009.11.032.

PMID:
20110008
13.

Health care resource utilization and medical costs of spinal cord injury with neuropathic pain in a commercially insured population in the United States.

Margolis JM, Juneau P, Sadosky A, Cappelleri JC, Bryce TN, Nieshoff EC.

Arch Phys Med Rehabil. 2014 Dec;95(12):2279-87. doi: 10.1016/j.apmr.2014.07.416. Epub 2014 Aug 24.

PMID:
25159715
14.

Burden of venous leg ulcers in the United States.

Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons N.

J Med Econ. 2014 May;17(5):347-56. doi: 10.3111/13696998.2014.903258. Epub 2014 Mar 24.

PMID:
24625244
15.

Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.

Ivanova JI, Birnbaum HG, Chen L, Duhig AM, Dayoub EJ, Kantor ES, Schiller MB, Phillips GA.

Am J Manag Care. 2011 Aug 1;17(8):e314-23.

16.

Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.

Joish VN, Spilsbury-Cantalupo M, Operschall E, Luong B, Boklage S.

Appl Health Econ Health Policy. 2013 Jun;11(3):299-304. doi: 10.1007/s40258-013-0027-z.

PMID:
23580074
17.

Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.

Allen LA, Smoyer Tomic KE, Smith DM, Wilson KL, Agodoa I.

Circ Heart Fail. 2012 Nov;5(6):672-9. doi: 10.1161/CIRCHEARTFAILURE.112.967356. Epub 2012 Oct 16.

18.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA.

Int J Chron Obstruct Pulmon Dis. 2012;7:757-64. doi: 10.2147/COPD.S36997. Epub 2012 Nov 1.

19.

Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and Medicare populations.

Suñer IJ, Margolis J, Ruiz K, Tran I, Lee P.

Retina. 2014 Nov;34(11):2250-8. doi: 10.1097/IAE.0000000000000217.

PMID:
25046390
20.

Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.

Bagalman E, Muser E, Choi JC, Durden E, Macfadden W, Haskins JT, Dirani R.

Clin Ther. 2011 Oct;33(10):1381-1390.e4. doi: 10.1016/j.clinthera.2011.09.005. Epub 2011 Oct 14. Erratum in: Clin Ther. 2011 Dec;33(12):2093.

PMID:
22000656
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk